(Q24186859)

1

0 references

Emmanuel Tsochatzis

3

0 references

Brian R Davidson

4

object named as

Brian R Davidson

0 references

Douglas Thorburn

2

object named as

Douglas Thorburn

0 references

author name string

Brian R Davidson

Cochrane Database of Systematic Reviews

4

0 references

publication date

1 September 1996

0 references

published in

0 references

cites work

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Risk and management of blood-borne infections in health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Distinct features in natural history and outcomes of acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Efficacy of new generation antidepressants: differences seem illusory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Checking consistency in mixed treatment comparison meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Global burden of disease (GBD) for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Case definitions for acute hepatitis C virus infection: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Acute hepatitis C: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Evolving epidemiology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Second generation direct antivirals and the way to interferon-free regimens in chronic HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Combination of direct and indirect evidence in mixed treatment comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Industry sponsorship and research outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

A comparison of methods to detect publication bias in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

How to use an article reporting a multiple treatment comparison meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Interferon for acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Intention-to-treat analysis: implications for quantitative and qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

The history of the "natural history" of hepatitis C (1968-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Outcome after liver transplantation for cirrhosis due to alcohol and hepatitis C: comparison to alcoholic cirrhosis and hepatitis C cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Mother to child transmission of hepatitis C virus: rate of infection and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Sample size and power considerations in network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Is sexual contact a major mode of hepatitis C virus transmission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN/UNOS data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Natural history of acute symptomatic hepatitis type C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Liver transplantation: a systematic review of long-term quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment of acute HCV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644

inferred from DOI database lookup

7 January 2021

based on heuristic

Interferon production by genetic engineering

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011644